Europlant Phytopharmacasp. z o.o.
Business and other management consultancy activities
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2001-10-19
Share capital
50,000.00 PLN
Registered address
1, 63-040 Klęka, Poland
Electronic delivery address
AE:PL-19944-78460-DHIAJ-24
Financials
Revenue history (in k)
Financial insight
- Possible Estonian CIT: Equity includes Art. 28d line items, but all amounts are 0 – this may be an accounting template or the first year of the regime.
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 233 days for 2023).
- 202528/07/2026
- 202410/07/2025
- 202305/03/2025
- 202211/07/2023
- 202102/09/2022
- 202012/07/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.42mMedianUSD 66.63kAverageUSD 1.19m
Net profit
This companyUSD 79.18kMedianUSD 1.81kAverageUSD 67.02k
Operating costs
This companyUSD 1.34mMedianUSD 50.39kAverageUSD 1.01m
Assets
This companyUSD 555.20kMedianUSD 69.66kAverageUSD 2.60m
Industry
Trademarks
Europlant Phytopharmaca holds 1 active trademark registered with the Polish Patent Office. The first mark was filed in 1995.
| Mark | Protected until | |
|---|---|---|
| EUROPLANT(word) | Aug 31, 2035 |
Authorized Representatives
Arkadiusz Szymurski – Management Board Member
Wojciech Skrobański – Management Board Member
Manner of representation
Both members of the management board represent the company jointly.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 100 | $13,506.21 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2003-12-31.
36 1090 1131 0000 0001 4214 9217
76 1090 1131 0000 0001 4214 6169
33 1090 1131 0000 0000 1300 9388
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Sep 21, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | –– | Prezes Zakładu Ubezpieczeń Społecznych |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Magnus Medical Społka z Ograniczoną Odpowiedzialnościąsp. z o.o. | $1,957,405.39 | magnusmedical.pl | ||
| FSG Biznessp. z o.o. | $1,860,978.55 | fsg.pl | ||
| Euro-Rowersp. z o.o. | $1,797,588.57 | euro-rower.pl | ||
| Griston Mgmtsp. z o.o. | $1,732,989.27 | gristonmgmt.com | ||
| CMT Family Officesp. z o.o. | $1,643,082.06 | cmt-family.pl | ||
| Ekocentrum Mssp. z o.o. | $1,635,454.21 | ekocentrumms.pl | ||
| Project Hubsp. z o.o. | $1,459,359.74 | projecthub.pl | ||
| DM Lexsp. z o.o. | $1,354,715.50 | dmlex.pl | ||
| SDM Group Servicesp. z o.o. | $1,196,926.44 | sdmgroup.pl | ||
| Semper Elirsp. z o.o. | $1,112,689.14 | semperelir.pl |
Change history
| Date | Event | |
|---|---|---|
| 2019-03-14 | Address change (1, 63-400, Klęka → 1, 63-040, Klęka) | |
| 2019-02-21 | Address change (Parkowa 5, 63-330, Dobrzyca → 1, 63-400, Klęka) | |
| 2019-02-21 | Name change (Phytopharm Dobrzyca → Europlant Phytopharmaca) | |
| 2003-09-01 | Share capital reduction (9,260,000.00 PLN → 50,000.00 PLN) | |
| 2001-10-19 | Entered in the register |
FAQ
The main business activity of Europlant Phytopharmaca focuses on business and other management consultancy activities.
The company was registered in the Polish National Court Register (KRS) on October 19, 2001.
The headquarters is located at: 1, 63-040 Klęka.
The management board consists of: Arkadiusz Szymurski (Member of the Management Board) and Wojciech Skrobański (Member of the Management Board).
The share capital of the company is PLN 50,000 (approx. $13,506).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of USD 1,420,460 in 2025, which is a decrease of 0.3% compared to 2024.
Yes, the company recorded a net profit of USD 79,179 in 2025, meaning the company increased its profit by 17.3%.
The largest operating cost category falls under employee remuneration. This category amounted to USD 1,036,825 in 2025, representing 77% of all operating expenses.
Last updated: 2026-10-29